Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients (CheckMate 141 and KEYNOTE 040)

Overview of attention for article published in Journal for Immunotherapy of Cancer, April 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 62 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 12 X posts from 10 X users, with an upper bound of 41,484 followers.

@alphavestcap $cue https://t.co/pTEXeICAuL. https://t.co/TT0mHf6qwj “Until CUE-101 trial no ..‘off-the-shelf‘ HPV-targeted biologic … with such durable responses ..for recurrent/metastatic HPV16+ HNC patients ; a significant advancement ; new thera

12 Nov 2021

Reply Repost Favourite

RT @sitcancer: #JITC Commentary: Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous ce…

23 Apr 2019

Reply Repost Favourite

RT @sitcancer: #JITC Commentary: Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous ce…

23 Apr 2019

Reply Repost Favourite

RT @sitcancer: #JITC Commentary: Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous ce…

22 Apr 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.